Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

New Drug Application (NDA): 021876
Company: DUCHESNAY
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
DICLEGIS DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE 10MG;10MG TABLET, DELAYED RELEASE;ORAL Prescription AB Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
04/08/2013 ORIG-1 Approval Type 5 - New Formulation or New Manufacturer STANDARD Label (PDF)
Letter (PDF)
Review
Summary Review (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021876s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021876Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/021876Orig1s000TOC.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/021876Orig1s000SumR.pdf
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
06/18/2018 SUPPL-13 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021876s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/021876Orig1s013ltr.pdf
03/10/2016 SUPPL-9 Manufacturing (CMC)

Label is not available on this site.

09/10/2015 SUPPL-8 Manufacturing (CMC)

Label is not available on this site.

06/23/2015 SUPPL-7 Manufacturing (CMC)

Label is not available on this site.

12/16/2014 SUPPL-6 Labeling-Container/Carton Labels Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/021876Orig1s006ltr.pdf
11/24/2014 SUPPL-5 Manufacturing (CMC)

Label is not available on this site.

07/30/2014 SUPPL-4 Manufacturing (CMC)

Label is not available on this site.

03/28/2014 SUPPL-3 Manufacturing (CMC)

Label is not available on this site.

09/30/2013 SUPPL-2 Manufacturing (CMC) Label (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021876s002lbl.pdf
01/29/2014 SUPPL-1 Manufacturing (CMC)

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
06/18/2018 SUPPL-13 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021876s013lbl.pdf
09/30/2013 SUPPL-2 Manufacturing (CMC) Label (PDF) This supplement type does not usually require new labeling. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021876s002lbl.pdf
04/08/2013 ORIG-1 Approval Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021876s000lbl.pdf

DICLEGIS

TABLET, DELAYED RELEASE;ORAL; 10MG;10MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
DICLEGIS DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE 10MG;10MG TABLET, DELAYED RELEASE;ORAL Prescription Yes AB 021876 DUCHESNAY
DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE 10MG;10MG TABLET, DELAYED RELEASE;ORAL Prescription No AB 205811 ACTAVIS LABS FL INC
DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE 10MG;10MG TABLET, DELAYED RELEASE;ORAL Prescription No AB 208518 PAR PHARM INC

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English